BIIB — Biogen Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual balance sheet for Biogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,803	4,893	1,050	2,375	3,816
Net Total Accounts Receivable
Net Total Receivables	1,962	2,136	2,100	1,869	1,867
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7,857	9,791	6,859	7,457	8,974
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,792	3,703	3,730	3,538	3,321
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	23,877	24,554	26,845	28,049	29,440
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,298	3,273	3,434	5,529	3,349
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	12,981	11,156	12,045	11,333	11,183
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	10,896	13,398	14,799	16,716	18,257
Total Liabilities & Shareholders' Equity	23,877	24,554	26,845	28,049	29,440
Total Common Shares Outstanding